Baricitinib
RxNorm 2047232
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2047232 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Baricitinib.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Baricitinib
(Atom ID: 10276271)
PTPrescribable
Designated preferred name (PT):
Baricitinib
(Atom ID: 9248992)
FNPrescribable
Full form of descriptor (FN):
Baricitinib (substance)
(Atom ID: 9248993)
PTPrescribable
Designated preferred name (PT):
Baricitinib-containing product
(Atom ID: 10797481)
FNPrescribable
Full form of descriptor (FN):
Product containing baricitinib (medicinal product)
(Atom ID: 10304583)
Patient Education
Baricitinib
Baricitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who have not responded well to one or more tumor necrosis factor (TNF) inhibitor medication(s). Baricitinib is in a class of medications called Janus kinase (JAK) inhibitors. It works by decreasing the activity of the immune system.
[Learn More]
* Please review the disclaimer below.